Controversial Saline: Questions Raised On The Quality Of West Bengal Pharmaceutical Firm

Kolkata:  Serious flaws have been found in the quality and sterilization process of saline manufactured by West Bengal Pharmaceutical. The Central Drugs Standard Control Organization (CDSCO) and State Drug Control have recommended an immediate halt to all activities of the company.

The State Drug Control Research Laboratory has revealed that several samples of the controversial saline are still pending for testing. An official admitted delay in the report due to lack of technicians. The report of the samples sent in June has not been prepared yet. After the intervention of the state health department, the report has been assured to be completed by this week.

In December, the Health Department of Karnataka also lodged complaints regarding the quality of Ringers Lactate Saline. The inspection conducted from December 4 to 6 revealed serious flaws in quality control and documentation. Necessary tests and records were not available.

In May 2023, about 32 thousand 500 Ringers Lactate were supplied to four districts of Karnataka. 27 complaints were registered, in which 16 samples failed the quality test. Blaming the use of this saline for the deaths of pregnant women, the Karnataka Health Department had sought the intervention of the Central Government. Despite this, the West Bengal government did not take notice and the company continued to supply goods. There are also allegations that the company had continuously given huge amounts of money as bribes to some officials of the Health Department.

The State Drug Control Research Laboratory said that the first 12 samples tested passed the quality test, but the report of the subsequent samples is still unknown. This problem has arisen due to lack of technicians and excessive workload. The laboratory should have 45 technicians, but there are only 12. To reduce the backlog, 20 technicians will soon be appointed on contract.

Related Posts

  • Pharma
  • June 25, 2025
  • 79 views
Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

A major face-off is expected in India’s growing anti-obesity treatment market, as Danish pharma giant Novo Nordisk rolled out its blockbuster weight-loss drug Wegovy on Tuesday, just a month after…

  • Pharma
  • June 25, 2025
  • 105 views
Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

Hyderabad:  Aurobindo Pharma Ltd wholly owned step-down subsidiary CuraTeQ Biologics has obtained marketing authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for Dyrupeg, its pegylated filgrastim biosimilar…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

Sun Pharma’s European partner withdraws application for skin cancer treatment therapy

Sun Pharma’s European partner withdraws application for skin cancer treatment therapy

Glenmark Pharma launches TEVIMBRA in India

Glenmark Pharma launches TEVIMBRA in India